BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1162 related articles for article (PubMed ID: 24946958)

  • 21. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging-guided radiofrequency ablation of solid renal tumors.
    Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
    AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
    Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
    Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
    Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
    Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preserved renal function after percutaneous radiofrequency ablation for renal tumors: experience of a single institution.
    Ofude M; Kitagawa Y; Koda W; Ueno S; Kadono Y; Konaka H; Mizokami A; Gabata T; Namiki M
    Anticancer Res; 2013 Oct; 33(10):4669-73. PubMed ID: 24123047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
    Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
    Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome.
    Park BK; Gong IH; Kang MY; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
    Eur Radiol; 2018 Jul; 28(7):2979-2985. PubMed ID: 29426988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses.
    Sung HH; Park BK; Kim CK; Choi HY; Lee HM
    Int J Hyperthermia; 2012; 28(3):227-34. PubMed ID: 22515344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
    Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
    J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
    Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
    AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.